Publication

Whole-brain 3D imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases

Neural Regeneration Research 15(12):2255-2257, 2020

Hansen HH, Roostalu U, Hecksher-Sørensen J

Share this page

Resource Library

Related resources

Quantitative whole-brain 3D imaging of congophilic parenchymal and vascular amyloid plaque architecture in a transgenic mouse model of Alzheimer’s disease

The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy

Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model

The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer’s disease

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650